Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-01-31

FDA Approved: XYZAL ALLERGY 24HR — Original Application (Chattem, Inc.)

View source ↗

Summary

FDA Approved: XYZAL ALLERGY 24HR (levocetirizine dihydrochloride) by Chattem, Inc. under an Original Application. The product is indicated for allergic rhinitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XYZAL ALLERGY 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

ORIG AP for XYZAL ALLERGY 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE)